The Analyst Verdict: Krystal Biotech In The Eyes Of 12 Experts
17/5 00:00
Krystal Biotech (NASDAQ:KRYS) has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days......